Glycomics Market is the study of the structure, function, and biosynthesis of carbohydrates, or sugars, found in living organisms. It is a rapidly growing field of research, and the market for glycomics products and services is expected to continue to expand in the coming years.
As the demand for more advanced glycomics solutions increases, so too does the potential for growth in the glycomics market. Companies are investing heavily in the development of new products, technologies, and services to meet the needs of researchers and clinicians. The global glycomics market was valued at USD 1.8 billion in 2022 and is expected to reach USD 3.7 billion by 2027, at a CAGR of 15.5%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
Key Market Players
Key players in the glycomics/glycobiology market are Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain) and Ray Biotech Life Inc. (US).
Merck KGaA is one of the leading players in the glycomics/glycobiology market. The company focuses on inorganic growth strategies such as investment to strengthen its market position. The company invested USD 20.52 Million to build new science laboratory in Switzerland for fostering the experiments and research.
One of the major drivers of the glycomics market growth is the growing application of glycomics in diagnostics and therapeutics. Glycomics is being used to develop novel drugs and therapies for a variety of diseases, from cancer to autoimmune disorders. In addition, glycomics is being used to develop treatments for metabolic disorders, such as diabetes, and neurological disorders, such as Alzheimer’s disease.
The rising prevalence of chronic diseases, along with the increasing demand for precision medicine, is also driving the growth of the glycomics market. As glycomics technologies become more advanced, they are being used to develop more effective treatments for a variety of diseases. In addition, the rapidly growing need for personalized medication is creating a need for more precise glycomics-based diagnostics and therapies.
The increasing investment in research and development in the field of glycomics is also contributing to the growth of the glycomics market. Governments and private organizations are investing heavily in the development of new technologies and products, which is driving the market forward.
The global glycomics market is highly competitive and consists of a number of players. Key players in the market include Merck KGaA, AbbVie Inc., Pfizer Inc., and GlaxoSmithKline plc, among others. These companies are investing heavily in research and development, and are expanding their product portfolios to gain a competitive advantage.
The future of the glycomics market looks bright, with the demand for more advanced solutions continuing to rise. Companies are investing heavily in research and development to develop new products and technologies to meet the growing needs of researchers and clinicians. As the market continues to expand, the potential for growth is strong.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
This report categorizes the glycomics/ glycobiology market into the following segments and subsegments
Glycomics/ Glycobiology Market, By Product
- Other Enzymes
- Mass Spectrometry Instruments
- Chromatography Instruments
- Other Instruments
- Glycan Releasing Kits
- Glycan Purification Kits
- Glycan Labeling Kits
- Other Kits
- Other Carbohydrates
- Reagents & Chemicals
Glycomics/ Glycobiology Market, By Application
- Drug Discovery & Development
- Cancer Diagnostics
- Other Diagnostics
- Other Applications
Glycomics/ Glycobiology Market, By End User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Clinical Laboratories
- Contract Research Organizations (CROs)
Glycomics/ Glycobiology Market, By Region
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- Bruker Corporation (US) acquired the IonSense (US) for expansion of the use of DART Mass spectrometers.
- GlycoNet (Canada) and BridgeBio Pharma Inc, (US) entered into partnership for developing medicines for treating genetic diseases through glycobiology research.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132685525
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Address:630 Dundee Road Suite 430
State: IL 60062
Country: United States